CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,568,000 | +11.2% | 800,000 | +23.1% | 3.26% | +24.3% |
| Q2 2023 | $21,203,000 | +0.4% | 650,000 | +8.3% | 2.62% | -38.3% |
| Q1 2023 | $21,114,000 | +15.2% | 600,000 | +50.0% | 4.25% | +10.6% |
| Q4 2022 | $18,328,000 | +8.1% | 400,000 | +14.3% | 3.85% | +16.8% |
| Q3 2022 | $16,958,000 | -17.8% | 350,000 | -33.3% | 3.29% | -22.4% |
| Q2 2022 | $20,627,000 | +19.2% | 525,000 | +11.7% | 4.24% | -5.8% |
| Q1 2022 | $17,301,000 | +16.8% | 470,000 | +44.6% | 4.50% | +9.8% |
| Q4 2021 | $14,814,000 | +27.5% | 325,000 | 0.0% | 4.10% | +22.8% |
| Q3 2021 | $11,616,000 | -16.1% | 325,000 | -53.6% | 3.34% | -12.5% |
| Q2 2021 | $13,853,000 | -14.9% | 700,000 | 0.0% | 3.81% | -18.0% |
| Q1 2021 | $16,282,000 | +49.2% | 700,000 | +33.3% | 4.65% | +43.4% |
| Q4 2020 | $10,910,000 | +152.0% | 525,000 | +162.5% | 3.24% | +145.1% |
| Q3 2020 | $4,330,000 | -46.0% | 200,000 | -41.2% | 1.32% | -44.8% |
| Q2 2020 | $8,014,000 | +112.4% | 340,000 | +6.2% | 2.40% | +44.4% |
| Q1 2020 | $3,773,000 | – | 320,000 | – | 1.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,106,989 | $14,159,000 | 2.50% |
| Healthcare Value Capital, LLC | 100,000 | $672,000 | 0.71% |
| First Light Asset Management, LLC | 218,792 | $1,470,000 | 0.69% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 435,202 | $2,925,000 | 0.67% |
| TFS CAPITAL LLC | 899,951 | $6,048,000 | 0.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 422,250 | $2,838,000 | 0.28% |
| ALGERT GLOBAL LLC | 73,181 | $492,000 | 0.27% |
| LANSDOWNE PARTNERS (UK) LLP | 2,321,865 | $15,603,000 | 0.13% |
| Leisure Capital Management | 17,567 | $118,000 | 0.12% |
| Rotella Capital Management, Inc. | 15,778 | $106,000 | 0.09% |